Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden

Thrombosis Research
Yoojoo LimSoo-Mee Bang

Abstract

Evidences suggest an association between leukocytosis and thrombotic or hemorrhagic complication in polycythemia vera (PV) and essential thrombocythemia (ET), but clinical implication is not well known. To evaluate whether leukocyte burden during follow-up is related to thrombotic or hemorrhagic events in PV and ET. We retrospectively analyzed patients with PV or ET treated at Seoul National University Bundang Hospital, Korea. Time-weighted averages of leukocytes during the follow-up period were defined as leukocyte burden and were calculated for each patient and compared between patient subgroups. In each patient with events, leukocyte burden for the 3-month period before the event was compared with that for the entire follow-up period. In 102 patients with PV or ET, 35 events (16 thrombotic, 19 hemorrhagic) occurred in 29 patients (median follow-up, 54months). Leukocyte burden were significantly higher in patients with events than in event-free patients (12,015×10(3) /μL vs. 9,567×10(3)/μL, P=0.003). The difference was more prominent in ET patients than in PV patients, and in patients with hemorrhagic events than in those with thrombotic events. In patients with events, the leukocyte burden in the pre-event period was higher ...Continue Reading

References

Nov 16, 2004·The American Journal of Medicine·Francesco PassamontiMario Lazzarino
Jan 26, 2005·British Journal of Haematology·M A Elliott, A Tefferi
Feb 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roberto MarchioliTiziano Barbui
Apr 27, 2005·Experimental Hematology·Anna FalangaTiziano Barbui
Jul 8, 2005·The New England Journal of Medicine·Claire N HarrisonUNKNOWN United Kingdom Medical Research Council Primary Thrombocythemia 1 Study
Nov 16, 2006·Blood·Raffaele LandolfiUNKNOWN European Collaboration on Low-Dose Aspirin in Polycythemia Vera (ECLAP)
Apr 30, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alessandra CarobbioTiziano Barbui
Feb 5, 2011·Journal of Neuropathology and Experimental Neurology·Iska Moxon-Emre, Lyanne C Schlichter
Sep 23, 2011·British Journal of Haematology·Francesca PalandriNicola Vianelli

❮ Previous
Next ❯

Citations

Nov 15, 2018·British Journal of Haematology·Mary F F McMullinUNKNOWN British Society for Haematology Guideline
Mar 9, 2019·Annals of Hematology·Martin GriesshammerCarlos Besses
Feb 23, 2019·Expert Review of Hematology·Barbara Mora, Francesco Passamonti
May 31, 2020·Molecular Biology Reports·Mohsen MalekniaNajmaldin Saki
Dec 21, 2019·Platelets·Dmitrii M PolokhovMikhail A Panteleev
Oct 2, 2019·Experimental and Therapeutic Medicine·Nan WangXiaohong Chen
Jul 24, 2021·Journal of Neurosciences in Rural Practice·Krishnan BalagopalJerin Peter Jacob
Nov 23, 2021·Journal of Cancer Research and Clinical Oncology·Carl C CrodelFlorian H Heidel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.